C-reactive protein and lung cancer risk: a Mendelian randomization analysis

被引：0
|
作者：
Panagiotou, Orestis A.
Caporaso, Neil E.
Landi, Maria T.
Chatterjee, Nilanjan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3445
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
    Wang, Xiaoliang
    Dai, James Y.
    Albanes, Demetrius
    Arndt, Volker
    Berndt, Sonja I.
    Bezieau, Stephane
    Brenner, Hermann
    Buchanan, Daniel D.
    Butterbach, Katja
    Caan, Bette
    Casey, Graham
    Campbell, Peter T.
    Chan, Andrew T.
    Chen, Zhengyi
    Chang-Claude, Jenny
    Cotterchio, Michelle
    Easton, Douglas F.
    Giles, Graham G.
    Giovannucci, Edward
    Grady, William M.
    Hoffmeister, Michael
    Hopper, John L.
    Hsu, Li
    Jenkins, Mark A.
    Joshi, Amit D.
    Lampe, Johanna W.
    Larsson, Susanna C.
    Lejbkowicz, Flavio
    Li, Li
    Lindblom, Annika
    Le Marchand, Loic
    Martin, Vicente
    Milne, Roger L.
    Moreno, Victor
    Newcomb, Polly A.
    Offitt, Kenneth
    Ogino, Shuji
    Pharoah, Paul D. P.
    Pinchev, Mila
    Potter, John D.
    Rennert, Hedy S.
    Rennert, Gad
    Saliba, Walid
    Schafmayer, Clemens
    Schoen, Robert E.
    Schrotz-King, Petra
    Slattery, Martha L.
    Song, Mingyang
    Stegmaier, Christa
    Weinstein, Stephanie J.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 767 - 780
  • [2] C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
    Allin, Kristine H.
    Nordestgaard, Borge G.
    Zacho, Jeppe
    Tybjaerg-Hansen, Anne
    Bojesen, Stig E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03): : 202 - 206
  • [3] C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis
    Zhu, Meng
    Ma, Zhimin
    Zhang, Xu
    Hang, Dong
    Yin, Rong
    Feng, Jifeng
    Xu, Lin
    Shen, Hongbing
    BMC MEDICINE, 2022, 20 (01)
  • [4] C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis
    Meng Zhu
    Zhimin Ma
    Xu Zhang
    Dong Hang
    Rong Yin
    Jifeng Feng
    Lin Xu
    Hongbing Shen
    BMC Medicine, 20
  • [5] Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study
    Habibi, Danial
    Daneshpour, Maryam S.
    Asgarian, Sara
    Kohansal, Karim
    Hadaegh, Farzad
    Mansourian, Marjan
    Akbarzadeh, Mahdi
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [6] Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study
    Danial Habibi
    Maryam S Daneshpour
    Sara Asgarian
    Karim Kohansal
    Farzad Hadaegh
    Marjan Mansourian
    Mahdi Akbarzadeh
    BMC Cardiovascular Disorders, 23
  • [7] Plasma C-Reactive Protein and Abdominal Aortic Aneurysm: A Mendelian Randomization Analysis
    Qin Xue-Ying
    Juan Juan
    Xiang Xiao
    Wei Ying-Qi
    Zuo Shang-Wei
    Huang Tao
    Chen Da-Fang
    Marshall Roger
    Xiong Jiang
    Guo Wei
    Hu Yong-Hua
    中华医学杂志(英文版), 2018, (21) : 2630 - 2633
  • [8] C-reactive protein and risk of lung cancer
    Chaturvedi, Anil
    Caporaso, Neil
    Katki, Hormuzd
    Wong, Hui -Lee
    Chatterjee, Nilanjan
    Pine, Sharon
    Chanock, Stephen
    Goedert, James
    Engels, Eric
    CANCER RESEARCH, 2010, 70
  • [9] C-Reactive Protein and Risk of Lung Cancer
    Chaturvedi, Anil K.
    Caporaso, Neil E.
    Katki, Hormuzd A.
    Wong, Hui-Lee
    Chatterjee, Nilanjan
    Pine, Sharon R.
    Chanock, Stephen J.
    Goedert, James J.
    Engels, Eric A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2719 - 2726
  • [10] Plasma C-Reactive Protein and Abdominal Aortic Aneurysm: A Mendelian Randomization Analysis
    Qin, Xue-Ying
    Juan, Juan
    Xiang, Xiao
    Wei, Ying-Qi
    Zuo, Shang-Wei
    Huang, Tao
    Chen, Da-Fang
    Marshall, Roger
    Xiong, Jiang
    Guo, Wei
    Hu, Yong-Hua
    CHINESE MEDICAL JOURNAL, 2018, 131 (21) : 2630 - +
12345